RNS System LGS Feasibility Study
RNS System LGS Feasibility Study
Active, not recruiting · NCT05339126 · Registry updated 2026-09-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| RNS System LGS Feasibility Study | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Epileptic Syndromes, Lennox-Gastaut syndrome, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Seizures, Generalized, Signs and Symptoms, brain disorder, central nervous system disorder, epilepsy, hereditary disease, nervous system disorder, visual epilepsy | Active, not recruiting | Phase 2 | 2026-09-15 | NCT05339126 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Institute of Neurological Disorders and Stroke (NINDS) | 370 |
| NeuroPace | 4 |
| University of Florida | 315 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Emory University | Atlanta | United States | 262 |
| Massachusetts General Hospital | Boston | United States | 1015 |
| Mount Sinai Hospital | New York | United States | 225 |
| NYU Langone Medical Center | New York | United States | 32 |
| University of Alabama at Birmingham | Birmingham | United States | 247 |
| University of California, San Francisco | San Francisco | United States | 294 |